Search Results 331-340 of 16012 for melatonin receptor agonists

  1. Metabolic Agents Pharmacodynamic Analyses After Brain Radiation - Mayo Clinic

    ... agonists. Note: Other protocol defined Inclusion/Exclusion Criteria may apply. Eligibility last updated 11/06/2024. Questions regarding updates should be ...

  2. Neurosurgery - Clinical trials

    Memantine hydrochloride may enhance cognitive function by binding to and inhibiting channels of receptors located in the central nervous system. Radiation ...

  3. Drugs and Supplements that Start with M - Mayo Clinic

    Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “M” to learn about drug side effects, proper use and ...

  4. Kalpana Muthusamy, M.B.B.S., M.D. - Mayo Clinic Faculty Profiles

    Dr. Muthusamy studies the risks of diabetes and the metabolic impact of endocrine adjuvant therapy in the setting of hormone receptor positive breast cancer.

  5. Skin Cancer Clinical Trials - Mayo Clinic Research

    This randomized pilot clinical trial studies melanoma antigen recognized by T-cells 1 (MART-1) antigen with or without toll-like receptor 4 (TLR4) agonist ...

  6. Sleep Restriction and Parental History of Hypertension - Mayo Clinic

    Use of melatonin supplements or any other over-the-counter sleep aid. Moderate-to-severe sleep disordered breathing (apnea/hypopnea index, AHI ≥ 15) or ...

  7. Ribociclib and letrozole (oral route) - Mayo Clinic

    Ribociclib and letrozole combination is used to treat hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER-2)-negative breast cancer.

  8. Olmesartan and hydrochlorothiazide (oral route) - Mayo Clinic

    Lowering blood pressure can reduce the risk of strokes and heart attacks. Olmesartan is an angiotensin II receptor blocker (ARB). It works by blocking a ...

  9. Monitoring Symptoms to Help Young Women Take Hormone Therapy for Stage I-III Breast Cancer, ASPEN Study - Mayo Clinic

    Participation eligibility · Participants must be female and have Stage I, II, or III hormone receptor positive breast cancer based on clinical or pathologic ...

  10. Publications - Bo E. Madsen, M.D., M.P.H. - Mayo Clinic

    Pharmacological characterization of homobaclofen on wild type and mutant GABA(B)1b receptors coexpressed with the GABA(B)2 receptor. Eur J Pharmacol. 2001 ...